PotlatchDeltic, Rayonier in all-stock merger; 1.7339x exchange
PotlatchDeltic (PCH) announced an all-stock merger of equals with Rayonier.
Rhea-AI Filing Summary
PotlatchDeltic (PCH) announced an all-stock merger of equals with Rayonier. Each PotlatchDeltic share will convert into 1.7339 Rayonier common shares at closing, with cash paid in lieu of fractional shares. Rayonier also declared a $1.40 per-share special dividend (up to 25% in cash, remainder in stock) payable on December 12, 2025 to holders of record on October 24, 2025; the merger exchange will be adjusted to reflect the stock and cash components of that dividend.
The combined company will have a new name, be headquartered in Atlanta, and feature a 10-member board (four directors from each company plus the two CEOs). Mark D. McHugh will serve as CEO and Eric J. Cremers as Executive Chair for two years. Closing is subject to shareholder approvals, HSR clearance, effectiveness of a Form S-4, and NYSE listing of the new shares. The outside date is July 13, 2026 with a possible 90-day extension for regulatory approvals.
Termination fees are $138,000,000 payable by PotlatchDeltic in certain circumstances and $159,000,000 payable by Rayonier in certain circumstances. PotlatchDeltic also approved accelerated vesting of director RSUs at closing and removed a six‑month seasoning requirement for double‑trigger vesting on employee RSUs/awards.
Positive
- Transformative all-stock merger: PCH holders to receive 1.7339 Rayonier shares per share, with adjustments for a $1.40 special dividend.
Negative
- None.
Insights
All-stock merger with fixed ratio and special dividend adjustment.
PotlatchDeltic and Rayonier agreed to a merger of equals. Each PotlatchDeltic share converts into 1.7339 Rayonier shares, with the ratio adjusted for Rayonier’s one-time $1.40 per-share special dividend (up to 25% cash, remainder stock). The mechanism increases the exchange ratio for the stock portion and adds a cash component per PotlatchDeltic share tied to the cash paid.
Governance is pre-set: a 10-member board, Mark D. McHugh as CEO and Eric J. Cremers as Executive Chair for two years, and headquarters in Atlanta. Closing requires shareholder approvals, HSR clearance, an effective Form S-4, and NYSE listing. The agreement includes an outside date of July 13, 2026 with a potential 90-day extension for regulatory approvals.
Financial protections include reverse and regular termination fees of $159,000,000 (Rayonier to PotlatchDeltic) and $138,000,000 (PotlatchDeltic to Rayonier), respectively. Equity awards convert based on an adjusted exchange formula, and PotlatchDeltic accelerates director RSUs at closing. Actual impact depends on approvals and completion of the special dividend mechanics.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PotlatchDeltic (PCH) announce?
When is the special dividend payable and what is the record date?
Where will the combined company be headquartered and who will lead it?
What approvals are required to close the PotlatchDeltic–Rayonier merger?
Is there an outside date for completing the merger?
Are there termination fees in this transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.